Cargando…

The Antipsychotic Medication Management Fidelity Scale: Psychometric properties

The paper describes the Antipsychotic Medication Management Fidelity Scale and its psychometric properties, including interrater reliability, frequency distribution, sensitivity to change and feasibility. Fidelity assessors conducted fidelity reviews four times over 18 months at eight sites receivin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruud, Torleif, Drivenes, Karin, Drake, Robert E., Haaland, Vegard Øksendal, Landers, Matthew, Stensrud, Bjørn, Heiervang, Kristin S., Tanum, Lars, Bond, Gary R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547997/
https://www.ncbi.nlm.nih.gov/pubmed/32030595
http://dx.doi.org/10.1007/s10488-020-01018-1
_version_ 1783592535128539136
author Ruud, Torleif
Drivenes, Karin
Drake, Robert E.
Haaland, Vegard Øksendal
Landers, Matthew
Stensrud, Bjørn
Heiervang, Kristin S.
Tanum, Lars
Bond, Gary R.
author_facet Ruud, Torleif
Drivenes, Karin
Drake, Robert E.
Haaland, Vegard Øksendal
Landers, Matthew
Stensrud, Bjørn
Heiervang, Kristin S.
Tanum, Lars
Bond, Gary R.
author_sort Ruud, Torleif
collection PubMed
description The paper describes the Antipsychotic Medication Management Fidelity Scale and its psychometric properties, including interrater reliability, frequency distribution, sensitivity to change and feasibility. Fidelity assessors conducted fidelity reviews four times over 18 months at eight sites receiving implementation support for evidence-based antipsychotic medication management. Data analyses shows good to fair interrater reliability, adequate sensitivity to change over time and good feasibility. At 18 months, item ratings varied from poor to full fidelity on most items. Use of the scale can assess fidelity to evidence-based guidelines for antipsychotic medication management and guide efforts to improve practice. Further research should improve and better calibrate some items, and improve the procedures for access to information. Trial registration: ClinicalTrials.gov Identifier: NCT03271242. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10488-020-01018-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7547997
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-75479972020-10-19 The Antipsychotic Medication Management Fidelity Scale: Psychometric properties Ruud, Torleif Drivenes, Karin Drake, Robert E. Haaland, Vegard Øksendal Landers, Matthew Stensrud, Bjørn Heiervang, Kristin S. Tanum, Lars Bond, Gary R. Adm Policy Ment Health Original Paper The paper describes the Antipsychotic Medication Management Fidelity Scale and its psychometric properties, including interrater reliability, frequency distribution, sensitivity to change and feasibility. Fidelity assessors conducted fidelity reviews four times over 18 months at eight sites receiving implementation support for evidence-based antipsychotic medication management. Data analyses shows good to fair interrater reliability, adequate sensitivity to change over time and good feasibility. At 18 months, item ratings varied from poor to full fidelity on most items. Use of the scale can assess fidelity to evidence-based guidelines for antipsychotic medication management and guide efforts to improve practice. Further research should improve and better calibrate some items, and improve the procedures for access to information. Trial registration: ClinicalTrials.gov Identifier: NCT03271242. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10488-020-01018-1) contains supplementary material, which is available to authorized users. Springer US 2020-02-06 2020 /pmc/articles/PMC7547997/ /pubmed/32030595 http://dx.doi.org/10.1007/s10488-020-01018-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Paper
Ruud, Torleif
Drivenes, Karin
Drake, Robert E.
Haaland, Vegard Øksendal
Landers, Matthew
Stensrud, Bjørn
Heiervang, Kristin S.
Tanum, Lars
Bond, Gary R.
The Antipsychotic Medication Management Fidelity Scale: Psychometric properties
title The Antipsychotic Medication Management Fidelity Scale: Psychometric properties
title_full The Antipsychotic Medication Management Fidelity Scale: Psychometric properties
title_fullStr The Antipsychotic Medication Management Fidelity Scale: Psychometric properties
title_full_unstemmed The Antipsychotic Medication Management Fidelity Scale: Psychometric properties
title_short The Antipsychotic Medication Management Fidelity Scale: Psychometric properties
title_sort antipsychotic medication management fidelity scale: psychometric properties
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547997/
https://www.ncbi.nlm.nih.gov/pubmed/32030595
http://dx.doi.org/10.1007/s10488-020-01018-1
work_keys_str_mv AT ruudtorleif theantipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT driveneskarin theantipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT drakeroberte theantipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT haalandvegardøksendal theantipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT landersmatthew theantipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT stensrudbjørn theantipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT heiervangkristins theantipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT tanumlars theantipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT bondgaryr theantipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT ruudtorleif antipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT driveneskarin antipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT drakeroberte antipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT haalandvegardøksendal antipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT landersmatthew antipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT stensrudbjørn antipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT heiervangkristins antipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT tanumlars antipsychoticmedicationmanagementfidelityscalepsychometricproperties
AT bondgaryr antipsychoticmedicationmanagementfidelityscalepsychometricproperties